<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>cholangiocarcinoma &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/cholangiocarcinoma/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 17 Sep 2025 17:22:05 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>cholangiocarcinoma &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Innovative RNA Therapy Targets CNNM4 Protein to Combat Rare Aggressive Liver Cancer</title>
		<link>https://bioengineer.org/innovative-rna-therapy-targets-cnnm4-protein-to-combat-rare-aggressive-liver-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 17 Sep 2025 17:21:53 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[cholangiocarcinoma]]></category>
		<category><![CDATA[CNNM4 protein]]></category>
		<category><![CDATA[ferroptosis]]></category>
		<category><![CDATA[GalNAc siRNA]]></category>
		<category><![CDATA[RNA therapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/innovative-rna-therapy-targets-cnnm4-protein-to-combat-rare-aggressive-liver-cancer/</guid>

					<description><![CDATA[A groundbreaking international study has unveiled a promising therapeutic target for cholangiocarcinoma (CCA), an exceptionally aggressive and rare form of liver cancer with limited treatment options. Published in the eminent journal Gut, the research highlights the pivotal role of the protein CNNM4, integral to magnesium transport within cells, and its overexpression in CCA tumors. This [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">269978</post-id>	</item>
	</channel>
</rss>
